Kids' immune response to respiratory infections study
Part of Infections, Lungs & breathing clinical trials.
This study looks at how South African children's immune systems respond to acute respiratory infections. It may help find better ways to treat or prevent these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Children must be aged 0 to 13 years old.
- They must have an acute respiratory tract infection, like a cold or pneumonia.
- They are receiving routine care at Tygerberg Hospital in Cape Town, South Africa.
- They must have been admitted to the hospital for at least 72 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new diagnostic tool to help doctors quickly identify the cause of respiratory infections (colds, flu, cough, sore throat, etc.) in children and teens. It aims to improve treatment decisions by guiding the use of antibiotics and other therapies.
This study watches babies under 29 days old to track and understand respiratory infections. It may help doctors learn how to better protect very young infants.
This study tracks patients with breathing problems to see which germs are making them sick. Doctors will use tests and medical records to watch for different pathogens.
This study tests whether a medicine called Ismigen can help children who get frequent respiratory infections (like colds, bronchitis, or throat infections) stay healthier. The medicine is made from bacterial components designed to strengthen the immune system.
This study looks at the burden of respiratory tract infections on hospitalized patients by reviewing existing hospital records. It may help improve care and resources for future patients with similar infections.
This study looks at how gut bacteria and immune markers relate to respiratory infections in children. It may help doctors understand why some children get sick more often and could lead to better treatments.
Hear when a new Mucosal Immunity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.